این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
یکشنبه 23 آذر 1404
مجله علوم اعصاب شفای خاتم
، جلد ۵، شماره ۲، صفحات ۱۱۲-۱۱۲
عنوان فارسی
P ۸۱: Omega-۳ Fatty Acid and Oxylipins in Management of Alzheimer Disease
چکیده فارسی مقاله
لطفاً به چکیده انگلیسی مراجعه شود.
کلیدواژههای فارسی مقاله
عنوان انگلیسی
P 81: Omega-3 Fatty Acid and Oxylipins in Management of Alzheimer Disease
چکیده انگلیسی مقاله
Neurodegenerative disease are characterized by the progressive loss of neurons from specific origins of the CNS .Alzheimer disease (AD) is a neurodegenerative disorder which affect brain regains that control memory and ability to learn. It is estimated that 27 million people are affected word wide and this number is expected to triple by 2050 due to increase of the population life expectancy. AD is becoming one of the most prevalent neurodegenerative conditions worldwide. Although the disease progression is becoming better understood, current medical interventions can only ameliorate some of the symptoms but cannot slow disease progression. Neuroinflammation, a specialized immune response that takes place in the central nervous system, has been linked to neurodegenerative diseases, and specially, it has been considered as a hallmark of Alzheimer disease. It plays an important role in the advancement of this disorder. Omega-3 (n-3) polyunsaturated fatty acids (PUFAs) are involved in both the reduction in and resolution of inflammation. These effects may be mediated by the anti-inflammatory and proresolving effects of bioactive lipid mediators (oxylipins) derived from n–3 PUFAs [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] in fish oil. Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids, (DHA) and (EPA), may have effects in psychiatric and behavioral symptoms in AD. Several studies indicate that Both DHA and EPA can reduce neuroinflammation and cognitive decline, but EPA positively influences mood disorders, whereas DHA maintains normal brain structure. The unique anti-inflammatory and pro-resolving properties of oxylipins from individual n–3 PUFAs will enable the discovery of novel disease-management strategies in AD.
کلیدواژههای انگلیسی مقاله
Omega-3 fatty acid, Oxylipins, Alzheimer disease
نویسندگان مقاله
کیمیا طراح | kimia tarrah
student of research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)
نشانی اینترنتی
http://shefayekhatam.ir/browse.php?a_code=A-10-24-931&slc_lang=en&sid=fa
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/337/article-337-393385.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
fa
موضوعات مقاله منتشر شده
تحقیقات پایه در علوم اعصاب
نوع مقاله منتشر شده
مروری
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات